CYP19A1 and breast cancer: Multiple clinical trials are currently evaluating the beneficial effects of curcumin for breast cancer prevention, combination-treatment (NCT03072992) and alleviating various breast cancer treatment-related side effects such as aromatase inhibitor-induced joint disease (NCT03865992).